|
||||||||||
| DVT Awareness | Join Our Email List | Thursday, September 02, 2010 | ||||||||||
Find Information on a:
View all Postings for:
Search ClotCare
|
Continuing Education OpportunitiesClotCare Online Resource does not offer continuing education credit. We do, however, provide information and links to continuing education opportunities that we feel may be of value to our users. We hope you find this list useful. If you know of a continuing education opportunity that you feel may be useful to other ClotCare users, please tell us about it. You may contact us at webmaster@clotcare.org. If you are specifically interested in anticoagulation training programs, check out our Training Programs page. The University of Illinois at Chicago Office of Continuing Education and Meeting Services-Programs offers a number of continuing education opportunities relating to anticoagulation and antithrombotic therapy. To review current opportunities, go to http://www.pharmacyce.uic.edu/Public/Catalog/ Thrombosis-Consult.com has a Free CME section that lists a number of Thrombosis-related CME opportunities. These listings are located at http://thrombosis.freecme.com/gallcourses.php ThrombosisClinic.com is a continuing medical education resource for health care professionals emphasizing the latest in emerging approaches in the diagnosis, treatment, and prevention of thrombosis. Visit http://www.ThrombosisClinic.com for more information.
HemostasisCME.org offers a number of continuing education opportunities relating to thrombosis. Visit http://www.hemostasiscme.org/ The ASHP has thrombosis-related CE programs and webinars online at www.improvingpatientoutcomes.com.
The heart.org has CE programs online at: Effectively Managing Oral Anticoagulation: 4 part series presented by Discovery Health featuring Jack E. Ansell, MD, B. Gail Macik, MD and Alan K. Jacobson, MD. discoveryhealthcme.discovery.com/beyond/miniPlayer.html?playerId=1225901422 Additional CE OpportunitiesPrograms no Longer Offering Credit
UC Davis Update on the Management of Thromboembolic DisordersOctober 11-13, 2010
The Meritage Hotel and Spa The nationally respected faculty presenting and interacting with participants at this activity include a principal author of the American College of Chest Physicians Evidence-Based Clinical Practice Guidelines for Prevention of Venous Thromboembolism (VTE), a member of the National Quality Forum steering committee for VTE initiatives, a nationally recognized leader in anticoagulation programs for pharmacists, an editorial board member for the American Thoracic Society's CHEST Journal, and an authority on cancer-related thrombosis and the role of the hemostatic system in sickle cell disease pathogenesis. Collectively, they have written hundreds of articles on anticoagulation management. Sponsored by UC Davis Health System
For online conference registration: https://chtapps.ucdmc.ucdavis.edu/
To print the brochure: http://www.ucdmc.ucdavis.edu/cme/ Real World Best Practices for DVT ProphylaxisCME Credit hours: 1.5 AMA PRA Category 1 credits
Release date: July 25, 2006 Program DescriptionVenous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. While unfractionated heparin (UFH) has been the standard treatment of VTE for many years, low-molecular-weight-heparins (LMWHs) are now commonly used as a therapeutic alternative. Effective prophylaxis and intervention are essential in minimizing VTE risk and reducing the incidence of life-threatening events. There exists a gap in knowledge for the treatment of VTE with secondary prophylaxis, acute PE, as well as a special consideration for the critically ill (e.g. volume overloaded) or patients with comorbidities (e.g. renal insufficiency). Furthermore, the existing clinical data needs to be discussed and interpreted in order to be applied, as well as a discussion surrounding current issues and controversies in VTE treatment and prophylaxis. This program provides concise and contemporary insight addressing concerns practitioners have regarding the management of patients with VTE. Target AudienceThis activity is intended for healthcare providers who treat DVT. Educational ObjectivesUpon completion of this educational activity participants will be able to:
Faculty
View Program
The program is available online at: Challenges in Dosing Low Molecular Weight HeparinCME Credit hours: 1.0
Release date: November 15, 2005 Program DescriptionAnticoagulants are used in a wide variety of patients, for both therapeutic purposes and as prophylaxis against thromboembolism. The efficacy of these agents has been well established in clinical trials. Unfractionated heparin can be hard to use, it binds to plasma proteins, and so there is wide variation in its anticoagulant effect. Vigilant monitoring of the PTT is necessary. Heparin-induced thrombocytopenia occurs about 3% of the time and this can be a big problem when it occurs. Low molecular weight heparins are produced by depolymerization of unfractionated heparin, rendering them smaller and thus more bioavailable. There is less binding to plasma proteins and less inactivation by platelet factor 4. Because of their more predicable effects, routine laboratory monitoring for dose adjustment is usually not required. There are solid clinical trial data indicating that low molecular weight heparins can be used as an alternative to unfractionated heparins. This program’s intention is NOT to review those data. Instead, this program features a discussion between four experts in critical care medicine. The discussion addresses the challenges in dosing and monitoring patients at the extremes of body weight, patients with renal insufficiency, and critically ill patients with altered plasma volume. Target AudienceThis activity is intended for Cardiologists, Hematologists, Intensivists, Pharmacists and other healthcare professionals who treat patients with LMWH. Educational ObjectivesUpon completion of this activity, participants will be able to:
Faculty
View Program
The program is available online at: Cancer and ThromboembolismPharmion Corporation has provided ClotCare Online Resource with a publication written by Joseph A. Caprini, MD, MS, FACS, RVT. This case presentation and discussion is entitled Management of Thromboembolism in Cancer Patients: A Case Presentation and Discussion. If you are interested in receiving CME credit for reviewing this publication, simply complete the questions provided and follow the instructions that accompany them. You will need Adobe Reader to view this document. You may download a free copy from Adobe's website at http://www.adobe.com/products/acrobat/readstep2.html. Read Management of Thromboembolism in Cancer Patients: A Case Presentation and Discussion |
|||||||||
|
Copyright 2000-2010 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information Send comments to webmaster@clotcare.org. ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate. |
||||||||||